Merck
- Business
Merck gains over $3.2B in sales from coronavirus pill in Q1
Pharmaceutical firm estimates $5 to $5.5B from COVID-19 pill this year US pharmaceutical firm Merck gained more than $3.2 billion…
Read More » - Business
Merck estimates up to $6B in sales from coronavirus pill in 2022
Company to supply 4 million courses of molnupiravir to 25 countries Merck estimates that it will rake in up to…
Read More »